Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months-Reference-Cited by-同舟云学术

Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months

Published:2020-10-16 Issue:10 Volume:15 Page:e0240905
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wouldes Trecia A.^ORCID,Woodward Lianne J.

Funder

Lottery Health Research

The Wayne Francis Charitable Trust

Cure Kids

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. United Nations Office on Drugs and Crime. World Drug Report. 2017.

2. CDC grand rounds: Prescription drug overdoses-a US epidemic;Centers for Disease Control and Prevention;Morbidity and Mortality Weekly Report,2012

3. Relationship between nonmedical prescription-opiod use and heroin use;WM Compton;The New England Journal of Medicine,2016

4. National trends in maternal use of opioid drugs among pregnancy-related hospitalizations in the United States, 1998 to 2009;HM Salihu;Am J Perinatol,2015

5. Neonatal drug withdrawal;American Academy of Pediatrics;Pediatrics,1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobehavioral outcomes of preterm infants: toward a holistic approach;Pediatric Research;2024-08-23

2. Evidence for neurobehavioral risk phenotypes at birth;Pediatric Research;2024-06-21

3. Newborn Neurobehavior and the Development of Infant Mental Health;WAIMH Handbook of Infant and Early Childhood Mental Health;2024

4. Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant;Frontiers in Pediatrics;2023-12-18

5. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice;Neuropharmacology;2023-12